Rheumatology News

TNF inhibitors have similar rates of adverse events and treatment response in ankylosing spondylitis regardless of whether the disease developed early or late in life, according to data published in Scientific Reports.

ORLANDO, Fla. — Cognitive behavioral therapy can help children and adolescents with rheumatic diseases cope with the challenges of their condition, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.

ORLANDO, Fla. — Allowing children with rheumatic diseases the time and space to formulate their own thoughts on their condition can facilitate communication and help them live a normal life, according to a presenter.

ORLANDO, Fla. — Including multiple specialists to treat the various facets of systemic sclerosis improves outcomes but can have its own challenges, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.

Despite being the second-most common rheumatic autoimmune disease in the United States, Sjögren’s syndrome remains under-recognized, with patients often waiting 3 years for a proper diagnosis, according to the Sjögren’s Foundation.

In this video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, calls out top stories in the July issue, including a cover story on chimeric antigen receptor T-cell therapy.

NEW YORK — In this Healio Video Perspective from the American Psychiatric Association Annual Meeting, Stefanie Simmons, MD, FACEP, chief medical officer of the Dr. Lorna Breen Heroes’ Foundation, discusses the Frontline Connect toolkit.

Nearly 1 year ago, I wrote my first editorial about the emergence and excitement surrounding the early experience with CAR T cells — CAR T Cells in Autoimmunity: A Potential Therapy About to Explode.

It has been at least 2 years since the first cohort of patients with lupus underwent chimeric antigen receptor T-cell treatment, and, at least so far, for every one of them, each new dawn represents another day spent in full remission.

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.